In a study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer. In the Cancer Medicine study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.
Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.
More strictly designed clinical trial studies are needed to replicate this finding."
Kai Wang, PhD., first author from Harvard University
Wang, K., et al. (2019) Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study. Cancer Medicine. doi.org/10.1002/cam4.2500.